Zhejiang Conba Pharmaceutical (600572.SH) has received two drug registration certificates.

Zhejiang Conba Pharmaceutical (600572.SH) announced that its wholly-owned subsidiary Zhejiang Jinhua Conba Pharmaceutical Biopharmaceutical Co., Ltd. (referred to as "Jinhua Zhejiang Conba Pharmaceutical") has received the Drug Registration Certificate issued by the National Medical Products Administration for the specifications of 2ml:5mg of Terbutaline Sulfate Nebulization Inhalation Solution and 2ml:0.5mg of Ipratropium Bromide Inhalation Solution.